Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Society of Interventional Radiology Reporting Standards for Thoracic Central Vein Obstruction: Endorsed by the American Society of Diagnostic and Interventional Nephrology (ASDIN), British Society of Interventional Radiology (BSIR), Canadian Interventional Radiology Association (CIRA), Heart Rhythm Society (HRS), Indian Society of Vascular and Interventional Radiology (ISVIR), Vascular Access Society of the Americas (VASA), and Vascular Access Society of Britain and Ireland (VASBI).

Literature DB >> 29503236

Society of Interventional Radiology Reporting Standards for Thoracic Central Vein Obstruction: Endorsed by the American Society of Diagnostic and Interventional Nephrology (ASDIN), British Society of Interventional Radiology (BSIR), Canadian Interventional Radiology Association (CIRA), Heart Rhythm Society (HRS), Indian Society of Vascular and Interventional Radiology (ISVIR), Vascular Access Society of the Americas (VASA), and Vascular Access Society of Britain and Ireland (VASBI).

Bart L Dolmatch¹, John C Gurley², Kevin M Baskin³, Boris Nikolic⁴, Jeffrey H Lawson⁵, Surendra Shenoy⁶, Theodore F Saad⁷, Ingemar Davidson⁸, Mark O Baerlocher⁹, Emil I Cohen¹⁰, Sean R Dariushnia¹¹, Salomão Faintuch¹², Bertrand Janne d'Othee¹³, Thomas B Kinney¹⁴, Mehran Midia¹⁵, James Clifton.

Abstract

Entities: Disease

Mesh：

Year: 2018 PMID： 29503236 DOI： 10.1016/j.jvir.2017.12.013

Source DB: PubMed Journal: J Vasc Interv Radiol ISSN： 1051-0443 Impact factor: 3.464

Keyword Cloud
Cited

× No keyword cloud information.

4 in total

1. Gianturco Z-stent placement for the treatment of chronic central venous occlusive disease: implantation of 208 stents in 137 symptomatic patients.

Authors: Joseph L McDevitt; Daryl T Goldman; Jacob J Bundy; Anthony N Hage; Neil K Jairath; Joseph J Gemmete; Ravi N Srinivasa; Jeffrey Forris Beecham Chick
Journal: Diagn Interv Radiol Date: 2021-01 Impact factor: 2.630

2. Efficacy and safety of recanalization with transseptal needle for chronic total occlusion of the brachiocephalic vein in hemodialysis patients.

Authors: Xi Yin; Xi Shen; Zhongxin Zhou; Qin Chen; Li Zhou; Tianlei Cui
Journal: Ann Transl Med Date: 2020-09

3. Efficacy and safety associated with the use of the Surfacer^® Inside-Out^® Access Catheter System: Results from a prospective, multicenter Food and Drug Administration-approved Investigational Device Exemption study.

Authors: Mahmood K Razavi; Eric K Peden; Ehab Sorial; John R Ross; John E Aruny; Timothy A Pflederer; Haimanot Wasse; Ziv J Haskal
Journal: J Vasc Access Date: 2020-06-27 Impact factor: 2.283

4. Use of Paclitaxel Coated Drug Eluting Technology to Improve Central Vein Patency for Haemodialysis Access Circuits: Any Benefit?

Authors: Tze Tec Chong; Hao Yun Yap; Chieh Suai Tan; Qingwei Shaun Lee; Sze Ling Chan; Ian Jun Yan Wee; Tjun Yip Tang
Journal: Vasc Specialist Int Date: 2020-03-31

4 in total

1. Gianturco Z-stent placement for the treatment of chronic central venous occlusive disease: implantation of 208 stents in 137 symptomatic patients.

2. Efficacy and safety of recanalization with transseptal needle for chronic total occlusion of the brachiocephalic vein in hemodialysis patients.

3. Efficacy and safety associated with the use of the Surfacer® Inside-Out® Access Catheter System: Results from a prospective, multicenter Food and Drug Administration-approved Investigational Device Exemption study.

4. Use of Paclitaxel Coated Drug Eluting Technology to Improve Central Vein Patency for Haemodialysis Access Circuits: Any Benefit?

3. Efficacy and safety associated with the use of the Surfacer^® Inside-Out^® Access Catheter System: Results from a prospective, multicenter Food and Drug Administration-approved Investigational Device Exemption study.